RAPT Therapeutics, Inc. (RAPT) Change in Acquisitions & Divestments (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Change in Acquisitions & Divestments for 5 consecutive years, with $30.0 million as the latest value for Q4 2024.
- Quarterly Change in Acquisitions & Divestments fell 60.56% to $30.0 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $135.0 million through Dec 2024, down 49.38% year-over-year, with the annual reading at $135.0 million for FY2024, 49.38% down from the prior year.
- Change in Acquisitions & Divestments hit $30.0 million in Q4 2024 for RAPT Therapeutics, down from $35.9 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $76.0 million in Q4 2023 to a low of $1.4 million in Q4 2021.
- Historically, Change in Acquisitions & Divestments has averaged $36.0 million across 5 years, with a median of $32.8 million in 2024.
- Biggest five-year swings in Change in Acquisitions & Divestments: tumbled 95.58% in 2021 and later surged 2483.41% in 2022.
- Year by year, Change in Acquisitions & Divestments stood at $32.3 million in 2020, then crashed by 95.58% to $1.4 million in 2021, then soared by 2483.41% to $36.9 million in 2022, then surged by 105.77% to $76.0 million in 2023, then plummeted by 60.56% to $30.0 million in 2024.
- Business Quant data shows Change in Acquisitions & Divestments for RAPT at $30.0 million in Q4 2024, $35.9 million in Q3 2024, and $36.4 million in Q2 2024.